ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,479,887, issued on Nov. 25, was assigned to Purdue Research Foundation (West Lafayette, Ind.).
"Inhibitors for protein n-terminal methyltransferase and uses thereof" was invented by Rong Huang (West Lafayette, Ind.), Dongxing Chen (West Lafayette, Ind.) and Guangping Dong (West Lafayette, Ind.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to series of peptidomimetic compounds as an inhibitor targeting protein N-terminal methyltransferase pharmacological pathway. Pharmaceutical compositions of those compounds and methods of using them in the treatment of diseases caused by abnormal protein methyltransferase pathway, includi...